Effects of Antibiotics on Gut Microbiota
The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
The gut microbiota influences essential human functions including digestion, energy metabolism, and inflammation by modulating multiple endocrine, neural, and immune pathways of the host. Its composition and complexity varies markedly across individuals and across different sites of the gut, but provides a certain level of resilience against external perturbation. Short-term antibiotic treatment is able to shift the gut microbiota to long-term alternative dysbiotic states, which may promote the development and aggravation of disease. Common features of post-antibiotic dysbiosis include a loss of taxonomic and functional diversity combined with reduced colonization resistance against invading pathogens, which harbors the danger of antimicrobial resistance. This review summarizes the antibiotic-related changes of the gut microbiota and potential consequences in health and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antibiotics (ATB) alter gut microbiota diversity and composition leading to dysbiosis, which may affect effectiveness of ICI.”
From Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer (2018) · cites this paper as [14]
In the citing paper
“16S ribosomal RNA sequencing of gene amplicons of patients' feces revealed that microbiota returns to its baseline within 1-3 months after ATB discontinuation.”
From Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer (2018) · cites this paper as [14]
In the citing paper
“However, some bacteria may take years to fully recover [14,20].”
From Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer (2018) · cites this paper as [14]
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Diversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788
Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
Bäckhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., Li, Y., Xia, Y., Xie, H., Zhong, H., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.004 · Cited by 3,315
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
A framework for human microbiome research
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11209 · Cited by 2,650
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Dethlefsen, L., & Relman, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000087107 · Cited by 2,421
Bifidobacteria can protect from enteropathogenic infection through production of acetate
Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J. M., Topping, D. L., Suzuki, T., et al. (2011) · Nature · doi:10.1038/nature09646 · Cited by 2,387
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361
The gut microbiota and host health: a new clinical frontier
Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. A., Hirschfield, G. M., Hold, G., Quraishi, M. N., Kinross, J., Smidt, H., Tuohy, K. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309990 · Cited by 2,302
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Zhu, L., Baker, S. S., Gill, C., Liu, W., Alkhouri, R., Baker, R. D., & Gill, S. R. (2013) · Hepatology · doi:10.1002/hep.26093 · Cited by 1,708
Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A.-L., Barnich, N., Bringer, M.-A., Swidsinski, A., Beaugerie, L., & Colombel, J.-F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.061 · Cited by 1,566
Microbiota-mediated colonization resistance against intestinal pathogens
Buffie, C. G., & Pamer, E. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3535 · Cited by 1,564
Gaboriau-Routhiau, V., Rakotobe, S., Lécuyer, E., Mulder, I., Lan, A., Bridonneau, C., Rochet, V., Pisi, A., De Paepe, M., Brandi, G., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.020 · Cited by 1,452
The Application of Ecological Theory Toward an Understanding of the Human Microbiome
Costello, E. K., Stagaman, K., Dethlefsen, L., Bohannan, B. J. M., & Relman, D. A. (2012) · Science · doi:10.1126/science.1224203 · Cited by 1,437
Jakobsson, H. E., Jernberg, C., Andersson, A. F., Sjölund-Karlsson, M., Jansson, J. K., & Engstrand, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009836 · Cited by 1,160
Long-term ecological impacts of antibiotic administration on the human intestinal microbiota
Jernberg, C., Löfmark, S., Edlund, C., & Jansson, J. K. (2007) · The ISME Journal · doi:10.1038/ismej.2007.3 · Cited by 1,134
In-feed antibiotic effects on the swine intestinal microbiome
Looft, T., Johnson, T. A., Allen, H. K., Bayles, D. O., Alt, D. P., Stedtfeld, R. D., Sul, W. J., Stedtfeld, T. M., Chai, B., Cole, J. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120238109 · Cited by 1,072
Human Gut Microbiome and Risk for Colorectal Cancer
Ahn, J., Sinha, R., Pei, Z., Dominianni, C., Wu, J., Shi, J., Goedert, J. J., Hayes, R. B., & Yang, L. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt300 · Cited by 947
Colonization resistance of the digestive tract in conventional and antibiotic-treated mice
Van der Waaij, D., Berghuis-de Vries, J. M., & Lekkerkerk-van der Wees, J. E. C. (1971) · Journal of Hygiene · doi:10.1017/s0022172400021653 · Cited by 901
Bacteremia among Children Admitted to a Rural Hospital in Kenya
Berkley, J. A., Lowe, B. S., Mwangi, I., Williams, T., Bauni, E., Mwarumba, S., Ngetsa, C., Slack, M. P. E., Njenga, S., Hart, C. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa040275 · Cited by 851
Quévrain, E., Maubert, M. A., Michon, C., Chain, F., Marquant, R., Tailhades, J., Miquel, S., Carlier, L., Bermúdez-Humarán, L. G., Pigneur, B., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-307649 · Cited by 841
Effect of antimicrobial agents on the ecological balance of human microflora
Sullivan, Å., Edlund, C., & Nord, C. E. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00066-4 · Cited by 818
Small molecules from the human microbiota
Donia, M. S., & Fischbach, M. A. (2015) · Science · doi:10.1126/science.1254766 · Cited by 760
Rutgeerts, P., Hiele, M., Geboes, K., Peeters, M., Penninckx, F., Aerts, R., & Kerremans, R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90121-3 · Cited by 743
Zoetendal, E. G., Raes, J., van den Bogert, B., Arumugam, M., Booijink, C. C. G. M., Troost, F. J., Bork, P., Wels, M., de Vos, W. M., & Kleerebezem, M. (2012) · The ISME Journal · doi:10.1038/ismej.2011.212 · Cited by 722
Butaye, P., Devriese, L. A., & Haesebrouck, F. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.175-188.2003 · Cited by 712
The composition of the gut microbiota shapes the colon mucus barrier
Jakobsson, H. E., Rodríguez‐Piñeiro, A. M., Schütte, A., Ermund, A., Boysen, P., Bemark, M., Sommer, F., Bäckhed, F., Hansson, G. C., & Johansson, M. E. (2015) · The EMBO Reports · doi:10.15252/embr.201439263 · Cited by 700
Regulated virulence controls the ability of a pathogen to compete with the gut microbiota
Kamada, N., Kim, Y.-G., Sham, H. P., Vallance, B. A., Puente, J. L., Martens, E. C., & Núñez, G. (2012) · Science · doi:10.1126/science.1222195 · Cited by 682
Raman, M., Ahmed, I., Gillevet, P. M., Probert, C. S., Ratcliffe, N. M., Smith, S., Greenwood, R., Sikaroodi, M., Lam, V., Crotty, P., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.015 · Cited by 672
Ou, J., Carbonero, F., Zoetendal, E. G., DeLany, J. P., Wang, M., Newton, K., Gaskins, H. R., & O’Keefe, S. J. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.056689 · Cited by 646
Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
Brandl, K., Plitas, G., Mihu, C. N., Ubeda, C., Jia, T., Fleisher, M., Schnabl, B., DeMatteo, R. P., & Pamer, E. G. (2008) · Nature · doi:10.1038/nature07250 · Cited by 631
Antimicrobial‐Associated Risk Factors for Clostridium difficile Infection
Owens, Jr., Donskey, C. J., Gaynes, R. P., Loo, V. G., & Muto, C. A. (2008) · Clinical Infectious Diseases · doi:10.1086/521859 · Cited by 603
Towards the Human Colorectal Cancer Microbiome
Marchesi, J. R., Dutilh, B. E., Hall, N., Peters, W. H. M., Roelofs, R., Boleij, A., & Tjalsma, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020447 · Cited by 552
Antibiotics, Pediatric Dysbiosis, and Disease
Vangay, P., Ward, T., Gerber, J. S., & Knights, D. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.006 · Cited by 530
Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice
Membrez, M., Blancher, F., Jaquet, M., Bibiloni, R., Cani, P. D., Burcelin, R. G., Corthesy, I., Macé, K., & Chou, C. J. (2008) · The FASEB Journal · doi:10.1096/fj.07-102723 · Cited by 493
Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study
Borzio, M., Salerno, F., Piantoni, L., Cazzaniga, M., Angeli, P., Bissoli, F., Boccia, S., Colloredo-Mels, G., Corigliano, P., Fornaciari, G., et al. (2001) · Digestive and Liver Disease · doi:10.1016/s1590-8658(01)80134-1 · Cited by 438
Sonnenburg, J. L., Angenent, L. T., & Gordon, J. I. (2004) · Nature Immunology · doi:10.1038/ni1079 · Cited by 404
Integrated Metagenomics/Metaproteomics Reveals Human Host-Microbiota Signatures of Crohn's Disease
Erickson, A. R., Cantarel, B. L., Lamendella, R., Darzi, Y., Mongodin, E. F., Pan, C., Shah, M., Halfvarson, J., Tysk, C., Henrissat, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049138 · Cited by 395
Members of the human gut microbiota involved in recovery from Vibrio cholerae infection
Hsiao, A., Ahmed, A. M. S., Subramanian, S., Griffin, N. W., Drewry, L. L., Petri, W. A., Haque, R., Ahmed, T., & Gordon, J. I. (2014) · Nature · doi:10.1038/nature13738 · Cited by 387
Ungaro, R., Bernstein, C. N., Gearry, R., Hviid, A., Kolho, K.-L., Kronman, M. P., Shaw, S., Van Kruiningen, H., Colombel, J.-F., & Atreja, A. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.246 · Cited by 384
“Blooming” in the gut: how dysbiosis might contribute to pathogen evolution.
Stecher, B., Maier, L., & Hardt, W.-D. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2989 · Cited by 378
Looft, T., Allen, H. K., Cantarel, B. L., Levine, U. Y., Bayles, D. O., Alt, D. P., Henrissat, B., & Stanton, T. B. (2014) · The ISME Journal · doi:10.1038/ismej.2014.12 · Cited by 373
Antibiotics, microbiota, and immune defense
Ubeda, C., & Pamer, E. G. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.05.003 · Cited by 356
Antibiotics as Part of the Management of Severe Acute Malnutrition
Trehan, I., Goldbach, H. S., LaGrone, L. N., Meuli, G. J., Wang, R. J., Maleta, K. M., & Manary, M. J. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1202851 · Cited by 351
Resilience of the Dominant Human Fecal Microbiota upon Short-Course Antibiotic Challenge
De La Cochetière, M. F., Durand, T., Lepage, P., Bourreille, A., Galmiche, J. P., & Doré, J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.11.5588-5592.2005 · Cited by 334
Antibiotic Use in Relation to the Risk of Breast Cancer
Velicer, C. M. (2004) · JAMA · doi:10.1001/jama.291.7.827 · Cited by 331
Takaishi, H., Matsuki, T., Nakazawa, A., Takada, T., Kado, S., Asahara, T., Kamada, N., Sakuraba, A., Yajima, T., Higuchi, H., et al. (2008) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.07.016 · Cited by 325
Schubert, A. M., Sinani, H., & Schloss, P. D. (2015) · mBio · doi:10.1128/mbio.00974-15 · Cited by 276
Tabibian, J. H., Weeding, E., Jorgensen, R. A., Petz, J. L., Keach, J. C., Talwalkar, J. A., & Lindor, K. D. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12232 · Cited by 267
Gerasimidis, K., Bertz, M., Hanske, L., Junick, J., Biskou, O., Aguilera, M., Garrick, V., Russell, R. K., Blaut, M., McGrogan, P., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000023 · Cited by 230
Enhanced Susceptibility to Salmonella Infection in Streptomycin-Treated Mice*
Bohnhoff, M., & Miller, C. P. (1962) · The Journal of Infectious Diseases · doi:10.1093/infdis/111.2.117 · Cited by 228
Drenick, E. J., Fisler, J., & Johnson, D. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80403-4 · Cited by 226
Färkkilä, M., Karvonen, A., Nurmi, H., Nuutinen, H., Taavitsainen, M., Pikkarainen, P., & Kärkkäinen, P. (2004) · Hepatology · doi:10.1002/hep.20457 · Cited by 218
Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease
Wieland, A., Frank, D. N., Harnke, B., & Bambha, K. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13376 · Cited by 207
Related actions of probiotics and antibiotics on gut microbiota and weight modification
Angelakis, E., Merhej, V., & Raoult, D. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70179-8 · Cited by 190
Lofmark, S., Jernberg, C., Jansson, J. K., & Edlund, C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl420 · Cited by 175
Stewardson, A. J., Gaïa, N., François, P., Malhotra-Kumar, S., Delémont, C., de Tejada, B. M., Schrenzel, J., Harbarth, S., & Lazarević, V. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.11.016 · Cited by 161
Vancomycin Treatment of Infective Endocarditis Is Linked with Recently Acquired Obesity
Thuny, F., Richet, H., Casalta, J.-P., Angelakis, E., Habib, G., & Raoult, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009074 · Cited by 152
Adamsson, I., Nord, C. E., Lundquist, P., Sjöstedt, S., & Edlund, C. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.5.629 · Cited by 145
Ou, J., DeLany, J. P., Zhang, M., Sharma, S., & O’Keefe, S. J. D. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.630164 · Cited by 144
Engstler, A. J., Aumiller, T., Degen, C., Dürr, M., Weiss, E., Maier, I. B., Schattenberg, J. M., Jin, C. J., Sellmann, C., & Bergheim, I. (2016) · Gut · doi:10.1136/gutjnl-2014-308379 · Cited by 136
Dik, V. K., van Oijen, M. G. H., Smeets, H. M., & Siersema, P. D. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3828-0 · Cited by 135
Harper, P. H., Truelove, S. C., Lee, E. C., Kettlewell, M. G. W., & Jewell, D. P. (1983) · Gut · doi:10.1136/gut.24.2.106 · Cited by 133
Silveira, M. G., Torok, N. J., Gossard, A. A., Keach, J. C., Jorgensen, R., Petz, R., & Lindor, K. D. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.14 · Cited by 129
Rossen, N. G., Fuentes, S., Boonstra, K., D’Haens, G. R., Heilig, H. G., Zoetendal, E. G., de Vos, W. M., & Ponsioen, C. Y. (2015) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jju023 · Cited by 129
Antibiotic use predicts an increased risk of cancer
Kilkkinen, A., Rissanen, H., Klaukka, T., Pukkala, E., Heliövaara, M., Huovinen, P., Männistö, S., Aromaa, A., & Knekt, P. (2008) · International Journal of Cancer · doi:10.1002/ijc.23622 · Cited by 122
Effect of Vancomycin on Intestinal Flora of Patients Who Previously Received Antimicrobial Therapy
Edlund, C., Barkholt, L., Olsson–Liljequist, B., & Nord, C. E. (1997) · Clinical Infectious Diseases · doi:10.1086/513755 · Cited by 115
Pouch Inflammation Is Associated With a Decrease in Specific Bacterial Taxa
Reshef, L., Kovacs, A., Ofer, A., Yahav, L., Maharshak, N., Keren, N., Konikoff, F. M., Tulchinsky, H., Gophna, U., & Dotan, I. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.041 · Cited by 108
Lane, J. A., Murray, L. J., Harvey, I. M., Donovan, J. L., Nair, P., & Harvey, R. F. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04610.x · Cited by 107
Macrolide antibiotics for cystic fibrosis
Southern, K. W., Barker, P. M., Solis-Moya, A., & Patel, L. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002203.pub3 · Cited by 95
Impact of antibiotic exposure on the risk of colorectal cancer: ANTIBIOTIC EXPOSURE AND CRC RISK
Boursi, B., Haynes, K., Mamtani, R., & Yang, Y.-X. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3765 · Cited by 89
Pallav, K., Dowd, S. E., Villafuerte, J., Yang, X., Kabbani, T., Hansen, J., Dennis, M., Leffler, D. A., Newburg, D. S., & Kelly, C. P. (2014) · Gut Microbes · doi:10.4161/gmic.29558 · Cited by 87
Role of Infections in the Manifestation or Reactivation of Inflammatory Bowel Diseases
Stallmach, A., & Carstens, O. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200205000-00009 · Cited by 80
Self-citationHeinsen, F.-A., Knecht, H., Neulinger, S. C., Schmitz, R. A., Knecht, C., Kühbacher, T., Rosenstiel, P. C., Schreiber, S., Friedrichs, A. K., & Ott, S. J. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1062959 · Cited by 75
Sullivan, A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg346 · Cited by 71
Björnsson, E., Cederborg, A., Åkvist, A., Simren, M., Stotzer, P.-O., & Bjarnason, I. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520510023288 · Cited by 70
Engelbrektson, A. L., Korzenik, J. R., Sanders, M. E., Clement, B. G., Leyer, G., Klaenhammer, T. R., & Kitts, C. L. (2006) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2006.00112.x · Cited by 51
Levine, A., & Turner, D. (2011) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2011.01.006 · Cited by 43
Yin, J., Prabhakar, M., Wang, S., Liao, S., Peng, X., He, Y., Chen, Y.-R., Shen, H.-F., Su, J., Chen, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126712 · Cited by 42
Recurrent Clostridium difficile infection and the microbiome
Almeida, R., Gerbaba, T. K., & Petrof, E. O. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1099-3 · Cited by 38
Mangin, I., Lévêque, C., Magne, F., Suau, A., & Pochart, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050257 · Cited by 35
Hentges, D. J. (1967) · Journal of Bacteriology · doi:10.1128/jb.93.4.1369-1373.1967 · Cited by 33
Nyberg, S. D., Österblad, M., Hakanen, A. J., Löfmark, S., Edlund, C., Huovinen, P., & Jalava, J. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701199790 · Cited by 31
van de Leur, J. J. J. P. M., Vollaard, E. J., Janssen, A. J. H. M., & Dofferhoff, A. S. M. (1997) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549709019046 · Cited by 23
History of antibiotic use and risk of non‐Hodgkin's lymphoma (NHL)
Kato, I., Koenig, K. L., Baptiste, M. S., Lillquist, P. P., Frizzera, G., Burke, J. S., Watanabe, H., & Shore, R. E. (2003) · International Journal of Cancer · doi:10.1002/ijc.11356 · Cited by 23
Gómez‐Hurtado, I., Moratalla, A., Moya-Pérez, Á., Peiró, G., Zapater, P., González-Navajas, J. M., Giménez, P., Such, J. M., Sanz, Y., & Francés, R. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.031 · Cited by 22
Hashash, J. G., Chintamaneni, P., Rivers, C. R., Κoutroubakis, I. E., Regueiro, M. D., Baidoo, L., Swoger, J. M., Barrie, A. M., Schwartz, M. B., Dunn, M. A., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000534 · Cited by 20
Cited by
Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders
Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00044 · Cited by 1,189
“There is growing evidence that nutritional components, such as probiotics (122, 123), gluten (124), as well as drugs, such as anti-oxidative agents (125) and antibiotics (126), have a high impact on vagus nerve activity through the interaction with the gut microbiota and that this effect varies greatly between individ…”
BackgroundAntibiotics as Major Disruptors of Gut Microbiota
Ramirez, J., Guarner, F., Bustos Fernandez, L., Maruy, A., Sdepanian, V. L., & Cohen, H. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.572912 · Cited by 898
“Antibiotic treatment reduces the overall diversity of gut microbiota species, including loss of some important taxa, which causes metabolic shifts, increases gut susceptibility to colonization, and stimulates the development of bacterial antibiotic resistance (Lange et al., 2016).”
BackgroundDerosa, L., Hellmann, M. D., Spaziano, M., Halpenny, D., Fidelle, M., Rizvi, H., Long, N., Plodkowski, A. J., Arbour, K. C., Chaft, J. E., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy103 · Cited by 908
Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview
Delgado-Rizo, V., Martínez-Guzmán, M. A., Iñiguez-Gutierrez, L., García-Orozco, A., Alvarado-Navarro, A., & Fafutis-Morris, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00081 · Cited by 686
“Clostridium difficile Clostridium difficile causes diarrhea and pseudomembranous colitis in humans, generally due to the abuse of antibiotics (79) that severely harm the host resident microbiota, leading to dysbiosis (80).”
BackgroundEpidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults
Stoffel, E. M., & Murphy, C. C. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.07.055 · Cited by 637
Metadata
- Authors
- Lange, K., Buerger, M., Stallmach, A., & Bruns, T.
- Affiliations
- Jena University Hospital (DE)
- Venue
- Digestive Diseases
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 34
- Issue
- 3
- Pages
- 260-268
- ISSN
- 0257-2753 (ISSN-L)
- 1421-9875
- OpenAlex
- W2320251182
- Cited by
- 607
- References
- 101
- Citations by year
- 2026: 36 · 2025: 51 · 2024: 92 · 2023: 96 · 2022: 99 · 2021: 79 · 2020: 48 · 2019: 46 · 2018: 33 · 2017: 19 · 2016: 7
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Digestive Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- antibiotics, gut microbiota, dysbiosis, colonization resistance, antimicrobial resistance, microbial diversity, host-microbe interactions, energy metabolism, inflammation, disease susceptibility
- MeSH terms
- Gastrointestinal Microbiome, Anti-Bacterial Agents, Humans, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.